Covered recipient · General Payments record
HAFEZ HALAWANI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$9,228.43
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,482.00 | 1 |
| Food and Beverage | $823.63 | 50 |
| Education | $264.98 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,521.61 | 6 |
| Astellas Pharma US Inc | $295.23 | 5 |
| Merck Sharp & Dohme Corporation | $103.02 | 5 |
| Acerta Pharma LLC | $81.31 | 5 |
| Daiichi Sankyo Inc. | $61.69 | 3 |
| Celgene Corporation | $54.55 | 3 |
| PFIZER INC. | $52.46 | 3 |
| Janssen Biotech, Inc. | $43.43 | 3 |
| Gilead Sciences, Inc. | $36.85 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.89 | 2 |
| SERVIER PHARMACEUTICALS LLC | $33.20 | 2 |
| Genentech USA, Inc. | $32.25 | 2 |
| Stemline Therapeutics Inc. | $30.64 | 2 |
| Karyopharm Therapeutics Inc. | $30.44 | 2 |
| JAZZ PHARMACEUTICALS INC. | $30.42 | 1 |
| Pharmacosmos Therapeutics Inc. | $27.46 | 2 |
| PharmaEssentia USA Corporation | $26.12 | 1 |
| TAIHO ONCOLOGY, INC. | $16.76 | 1 |
| BeiGene USA, Inc. | $16.11 | 1 |
| Ipsen Biopharmaceuticals, Inc | $15.37 | 1 |
| Amgen Inc. | $13.94 | 1 |
| GENZYME CORPORATION | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.